Literature DB >> 23844336

Early age-related progression of AD-like neuropathology in Down's syndrome.

Larry D Sparks1, Richard J Kryscio, John C Hunsaker.   

Abstract

We have previously reported that increased numbers of Alz-50-reactive (apoptotic) neurons occurred in young DS subjects compared to controls, but increased in density with increasing age, and in advance of identifiable senile plaques (SP) in DS. The purpose of the study was to determine if there are further differences in Alzheimer's disease (AD)-like neuropathology with increasing age among individuals with Down's syndrome (DS) compared to cognitively normal age-matched controls. The two populations compared were age-matched normal controls (N = 14) between 11 months and 61 years of age and individuals with DS (N = 8) between 1 and 54 years of age. There were 7 cognitively intact DS and 10 control subjects under 35 years of age. The single demented 54 year old DS subject was compared to 4 non-demented controls between 48 and 61 years of age. 50 μm Vibratome sections of formalin fixed hippocampal formations were immunohistochemically stained for amyloid-β (6E10), APP (22C11) and phosphorylated tau (AT8) using standard methods. AT8 immunoreactive features were found only in the oldest DS subject. In contrast, the number and intensity of amyloid-β-immunoreactive neurons were maximal in the youngest DS subjects (1-24 years), reduced in the young adults (25-35 years) synchronous with the appearance of only diffuse-form SP, and were further reduced in the 54 year-old DS subject exhibiting abundant multiform SP. Distribution of APP immunoreactivity (22C11) was distinct from amyloid-β (6E10) in appearance and by location and age in both DS and normal controls. The data indicates that the earliest observable neuropathologic feature in DS may be neuronal accumulation of amyloid-β. Such accumulation of amyloid-β occurs decades in advance of deposition as SP, which in turn occurs decades before cognitive decline.

Entities:  

Keywords:  Amyloid-β; amyloid-β precursor protein; phospho-tau

Year:  2013        PMID: 23844336      PMCID: PMC3703124     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  14 in total

1.  Adaptive behaviour in Down syndrome: a cross-sectional study from childhood to adulthood.

Authors:  Anastasia Dressler; Valentina Perelli; Martha Feucht; Stefania Bargagna
Journal:  Wien Klin Wochenschr       Date:  2010-12-07       Impact factor: 1.704

2.  Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain.

Authors:  J Motte; R S Williams
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Individual and environmental characteristics associated with cognitive development in Down syndrome: a longitudinal study.

Authors:  Donna Couzens; Michele Haynes; Monica Cuskelly
Journal:  J Appl Res Intellect Disabil       Date:  2012-01-02

4.  Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia.

Authors:  D M Mann; M C Royston; C R Ravindra
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

5.  Aging in adults with Down syndrome: report from a longitudinal study.

Authors:  D B Burt; K A Loveland; Y W Chen; A Chuang; K R Lewis; L Cherry
Journal:  Am J Ment Retard       Date:  1995-11

6.  Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging.

Authors:  C Pallister; S S Jung; I Shaw; J Nalbantoglu; S Gauthier; N R Cashman
Journal:  Neurobiol Aging       Date:  1997 Jan-Feb       Impact factor: 4.673

7.  Down's syndrome: occurrence of ALZ-50 reactive neurons and the formation of senile plaques.

Authors:  D L Sparks; J C Hunsaker
Journal:  J Neurol Sci       Date:  1992-05       Impact factor: 3.181

8.  Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.

Authors:  P R Hof; C Bouras; D P Perl; D L Sparks; N Mehta; J H Morrison
Journal:  Arch Neurol       Date:  1995-04

9.  Beta A4 deposition in the temporal cortex of adults with Down's syndrome.

Authors:  E Spargo; P J Luthert; I Janota; P L Lantos
Journal:  J Neurol Sci       Date:  1992-08       Impact factor: 3.181

Review 10.  Neuropathology of sudden infant death (syndrome): literature review and evidence of a probable apoptotic degenerative cause.

Authors:  D Larry Sparks; John C Hunsaker
Journal:  Childs Nerv Syst       Date:  2002-09-04       Impact factor: 1.475

View more
  2 in total

1.  Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome.

Authors:  Emma C Utagawa; David G Moreno; Kristian T Schafernak; Nicoleta C Arva; Michael H Malek-Ahmadi; Elliott J Mufson; Sylvia E Perez
Journal:  Acta Neuropathol Commun       Date:  2022-06-08       Impact factor: 7.578

2.  Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Authors:  Ruma Raha-Chowdhury; James W Henderson; Animesh Alexander Raha; Simon R W Stott; Romina Vuono; Simona Foscarin; Liam Wilson; Tiina Annus; Robert Fincham; Kieren Allinson; Vinod Devalia; Robert P Friedland; Anthony Holland; Shahid H Zaman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.